- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07619469
Motion Sickness Severity and Sensorimotor Performance
May 26, 2026 updated by: Yunus Emre Tutuneken, Istinye University
The Relationship of Balance, Proprioception, Coordination, and Reaction Time Measurements With Motion Sickness Severity in Individuals With Motion Sickness: A Cross-Sectional Study
Background: Motion sickness (MS) is a common syndrome characterized by autonomic and behavioral symptoms, such as nausea and dizziness, resulting from exposure to motion stimuli.
Its pathophysiology is closely linked to sensory conflict and postural instability theories.
While previous studies suggest that postural control, proprioception, and reaction times are affected in individuals susceptible to MS, there is a lack of comprehensive, comparative research evaluating all these parameters concurrently within the same cohort using standardized methods.
Objective: This study aims to systematically measure balance, proprioceptive sensitivity, coordination, and reaction time parameters, and quantitatively analyze their relationship with motion sickness severity.
Methodology: In this prospective, cross-sectional study, at least 41 participants aged 18-40 with motion sickness will be recruited.
Participants will undergo motion sickness susceptibility and severity grading using the Motion Sickness Susceptibility Questionnaire Short Form (MSSQ-SF) and the Graybiel Scale.
Objective assessments will include static and dynamic balance testing (ProKin®), knee joint position sense (Clinometer app), manual dexterity and dynamic balance coordination (Nine-Hole Peg Test, Tandem Walk, Romberg Test), and upper/lower extremity reaction time measurements (BlazePod system).
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
41
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The study population consists of adult individuals aged between 18 and 40 years who exhibit susceptibility to motion sickness.
Description
Inclusion Criteria:
- Individuals aged between 18 and 40 years.
- Diagnosed with motion sickness according to the Motion Sickness -Susceptibility Questionnaire Short Form (MSSQ-SF).
- Normal hearing acuity.
- No history of acute or chronic vestibular disease, other than motion sickness.
- Normal or corrected-to-normal vision.
- Adequate physical capability to fully perform the measurement protocols, including balance, proprioception, coordination, and reaction time tests.
Exclusion Criteria:
- Presence of any physical or orthopedic problem that could interfere with testing.
- History of acute or chronic instability, unsteadiness, or vertigo.
- Severe visual impairment.
- History of prior ear surgery.
- Presence of any neurological condition or disorder.
- History of migraines.
- Current use of medications that could affect balance or vestibular function (e.g., vestibular suppressants, sedatives).
- Use of alcohol or psychoactive substances within the last 48 hours prior to testing.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motion Sickness Severity (Graybiel Score)
Time Frame: 1 hour
|
Used to grade the clinical severity of acute motion sickness symptoms (including nausea, cold sweating, increased salivation, and dizziness) following a randomized chair-rotation provocation protocol.
|
1 hour
|
|
Static Balance
Time Frame: 1 hour
|
Evaluated objectively using the ProKin® computerized balance system.
Participants stand on the platform under conditions: double-leg with eyes open.
|
1 hour
|
|
Dynamic Balance Performance
Time Frame: 1 hour
|
Evaluated using the ProKin® system.
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knee Joint Proprioception
Time Frame: 1 hour
|
Evaluated in supine and prone positions, targeting knee angles of 15°, 30°, 60°, and 90° using the Clinometer digital inclinometer smartphone application.
|
1 hour
|
|
Nine-Hole Peg Test (9HPT) Completion Time
Time Frame: 1 hour
|
Used to assess upper extremity dexterity and fine motor coordination.
Participants place nine pegs into the holes one by one and then remove them as quickly as possible.
|
1 hour
|
|
Tandem Walk Test Error Count
Time Frame: 1 hour
|
Participants walk barefoot along a straight line for 10 steps, placing the heel of one foot directly against the toe of the other foot with arms relaxed at their sides.
|
1 hour
|
|
Visual Reaction Time
Time Frame: 1 hour
|
Evaluated using the mobile application-based BlazePod.
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
August 2, 2026
Study Completion (Estimated)
August 5, 2026
Study Registration Dates
First Submitted
May 26, 2026
First Submitted That Met QC Criteria
May 26, 2026
First Posted (Actual)
June 2, 2026
Study Record Updates
Last Update Posted (Actual)
June 2, 2026
Last Update Submitted That Met QC Criteria
May 26, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dizziness
-
Boston Children's HospitalNot yet recruitingVestibular Migraine | Chronic Dizziness | Persistent Postural Perceptual DizzinessUnited States
-
Mayo ClinicRecruitingChronic Dizziness | Persistent Postural Perceptual DizzinessUnited States
-
Assiut UniversityNot yet recruiting
-
Guy's and St Thomas' NHS Foundation TrustKing's College LondonCompletedVestibular Disease | Chronic Dizziness | Persistent Postural Perceptual DizzinessUnited Kingdom
-
Hospital Clinico Universitario de SantiagoInstituto de Salud Carlos III; European Regional Development FundUnknownFall | Dizziness ChronicSpain
-
University Hospital, CaenRecruiting
-
Hospital Clinico Universitario de SantiagoInstituto de Salud Carlos III; European Regional Development FundCompletedFall | Elderly | Dizziness Chronic
-
University of JordanCompleted
-
Kyunghee UniversityWithdrawn
-
Ludwig-Maximilians - University of MunichCompletedVertigo | Bilateral Vestibulopathy | Functional DizzinessGermany
Clinical Trials on Standardized Sensorimotor Assessment and Motion Sickness Provocation Protocol
-
Eastern Mediterranean UniversityRecruitingAthletic Performance | Postural BalanceCyprus
-
Universitat Internacional de CatalunyaEnrolling by invitationMigraine | Primary Headache Disorders | Tension-type Headache | Tension Headache | Chronic Overlapping Pain DisordersSpain